← Back to Search

Continuous Glucose Monitor

Dexcom G6 Continuous Glucose Monitor for Hypoglycemia (IMPaCT Trial)

N/A
Waitlist Available
Led By Risa Wolf, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Diagnosis of Type 1 diabetes for \>3 months
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using the Dexcom G6 CGM system helps children with poorly controlled Type 1 diabetes manage their blood sugar better. The device continuously monitors blood sugar levels and provides real-time data. This could help these children and their caregivers make better decisions about their diabetes care.

Eligible Conditions
  • Hypoglycemia
  • Type 1 Diabetes
  • Low Blood Sugar
  • High Blood Sugar

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Personal CGM Use
Secondary study objectives
Change in Hemoglobin A1c
Change in the Percent Time in Range Glucose Control
Using Personal CGM

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dexcom G6 Continuous Glucose MonitorExperimental Treatment1 Intervention
Children with type 1 diabetes will wear a continuous glucose monitor (CGM) for 10 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexcom G6 Continuous Glucose Monitor
2021
N/A
~30

Find a Location

Who is running the clinical trial?

DexCom, Inc.Industry Sponsor
144 Previous Clinical Trials
35,459 Total Patients Enrolled
12 Trials studying Hypoglycemia
15,901 Patients Enrolled for Hypoglycemia
Johns Hopkins UniversityLead Sponsor
2,325 Previous Clinical Trials
14,874,854 Total Patients Enrolled
3 Trials studying Hypoglycemia
70 Patients Enrolled for Hypoglycemia
Risa Wolf, MDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
164 Total Patients Enrolled
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top